Chembio Diagnostics Gross Profit

Chembio Diagnostics (CEMI) currently reports a gross profit of $9.8M as of December 2022. That compares with $2.4M in the prior-year period — up 301.6% year over year. That is below the Healthcare sector average of $66B. Use the charts on this page to explore Chembio Diagnostics's gross profit history and peer comparisons.

Chembio Diagnostics's gross profit increased from $2.4M to $9.8M — a 301.6% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chembio Diagnostics's gross profit of $9.8M is lower than the Healthcare sector average of $66B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Chembio Diagnostics reported $9.8M in gross profit as of December 2022. That compares with $2.4M in the prior-year period — up 301.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $9.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $66B. From there, open related valuation or income-statement pages for Chembio Diagnostics, and consider following CEMI for alerts when major investors trade the stock.